New Phase Research & Development — Knoxville, Tennessee

New Phase Research & Development is a clinical research site located in Knoxville, Tennessee, United States 37909.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

New Phase Research & Development has participated in 33 clinical trials with 4 currently active.

Therapeutic areas: Diabetes Mellitus, Type 2, Irritable Bowel Syndrome With Diarrhea (IBS-D), Type 2 Diabetes.

Sponsors: Gan and Lee Pharmaceuticals, USA, Ironwood Pharmaceuticals, Inc., Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New Phase Research & Development?

New Phase Research & Development has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New Phase Research & Development conducted?

New Phase Research & Development has 33 clinical trials on record, with 4 currently active. Their work covers Diabetes Mellitus, Type 2, Irritable Bowel Syndrome With Diarrhea (IBS-D), Type 2 Diabetes.

Is New Phase Research & Development accredited by Crixeo Health?

Yes — New Phase Research & Development holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about New Phase Research & Development?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.